ArticleCytoJournal2024

Expression and clinical significance of programmed death ligand-1 evaluated by 22C3 antibody in pleural effusion metastatic non-small-cell lung cancer.

Dongmei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.